RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R10202 | AZD4547 | AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 |
| R10233 | Tyrphostin A9;Tyrphostin 9; Malonoben | Tyrphostin 9 is firstly designed as an EGFR inhibitor with IC50 of 460 μM, but i |
| R10235 | GSK1838705A | GSK1838705A is a potent and reversible IGF-IR and the insulin rec |
| R10253 | Dacomitinib，PF299804 | Dacomitinib (PF299804, PF299) is a potent, irreversible pan-ErbB inhibitor, most |
| R10254 | AZD9291 Mesylate | AZD-9291 is a potent and selective mutated forms EGFR inhibitor(Exon 19 deletion |
| R10255 | LY2874455; dovitinib | LY2874455 is a pan-FGFR inhibitor with IC50 of 2.8 nM, 2.6 nM, 6.4 nM, and 6 nM |
| R10256 | Blu9931 | BLU9931 is a potent, highly selective, and irreversible fibroblast growth factor |
| R10259 | AG490 | AG-490 (Tyrphostin B42) is an inhibitor of EGFR with IC50 of 0.1 μM in cell-free |
| R10283 | Nintedanib esylate; BIBF1120 esylate | Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, |
| R10296 | Afatinib; BIBW2992 | Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L85 |
| R10331 | Cabozantinib S-malate (XL184 S-malate; BMS-907351 S-malate) | abozantinib malate (XL184) is the malate of Cabozantinib, a potent VEGFR2 inhibi |
| R10339 | PLX-3397; Pexidartinib | Pexidartinib (PLX3397) is an oral, potent mutil-targeted receptor tyrosine kinas |
| R10358 | Nintedanib; BIBF1120; Vargatef | Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, |
| R10448 | Imatinib; STI571 | Imatinib (STI571) is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC5 |
| R10449 | Gefitinib; ZD1839 | Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 |
| R10514 | Axitinib; AG013736 | Axitinib is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ and c-Kit |
| R10535 | Afatinib dimaleate; BIBW2992 dimaleate | Afatinib (BIBW2992) Dimaleate irreversibly inhibits EGFR/HER2 including EGFR(wt) |
| R10540 | Regorafenib monohydrate | Regorafenib is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFR??, Kit |
| R10545 | CANGRELOR | Regorafenib is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFR, Kit, |
| R10569 | Pelitinib | Pelitinib (EKB-569) is a potent irreversible EGFR inhibitor with IC50 of 38.5 nM |
| R10585 | AZD3759 | AZD3759 is a potent, oral active, central nervous system-penetrant, EGFR inhibit |
| R10699 | AG18 | AG-18 inhibits EGFR with IC50 of 35 μM. |
| R10711 | AG-1517 | PD153035 HCl is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 |
| R10727 | Quizartinib;AC-220 | Quizartinib (AC220) is a second-generation FLT3 inhibitor for Flt3(ITD/WT) with |
| R10733 | Semaxinib;SU5416 | Semaxanib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor with IC5 |
